Health IT Analytics February 20, 2018
Artificial intelligence and mHealth apps can improve clinical trial participation and efficiency, but industry resistance and immature data analytics slow implementation.
Artificial intelligence (AI) and mHealth applications can accelerate clinical trial innovation by enhancing patient participation and optimizing efficiency, but organizational resistance and underdeveloped data analytics are barriers to stakeholder adoption, according to a Deloitte report.
As consumer expectations have evolved, clinical trial participants have come to demand a more patient-friendly experience. However, the report points out that the industry has been slow to meet even the most basic expectations.
Traveling to clinical sites is a major burden for clinical trial participants and can reduce their willingness and ability to participate. According to the report, 70 percent of potential participants...
Today's Sponsors
Today's Sponsor